Brief Introduction:
National Medical Insurance, Category B.
Launched in 2016.
1st 40kD Y-shape branched PEG modified interferon alfa-2b injection in the world.
National class 1 new drug, therapeutic biological products.
The 1st drug approved to be combined with nucleos(t)ide analogues for the sustained HBsAg clearance in adult CHB patients.
Indications:
Chronic hepatitis B. For details, please refer to Instructions.